Related references
Note: Only part of the references are listed.PTEN, DICER1, FH, and Their Associated Tumor Susceptibility Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood
Kris Ann P. Schultz et al.
CLINICAL CANCER RESEARCH (2017)
Whole-gene CFTR sequencing combined with digital RT-PCR improves genetic diagnosis of cystic fibrosis
Letizia Straniero et al.
JOURNAL OF HUMAN GENETICS (2016)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
DICER1: mutations, microRNAs and mechanisms
William D. Foulkes et al.
NATURE REVIEWS CANCER (2014)
BRCA2 Deep Intronic Mutation Causing Activation of a Cryptic Exon: Opening toward a New Preventive Therapeutic Strategy
Olga Anczukow et al.
CLINICAL CANCER RESEARCH (2012)
Fine-tuning oligodendrocyte development by microRNAs
Olga Barca-Mayo et al.
FRONTIERS IN NEUROSCIENCE (2012)
Extending the phenotypes associated with DICER1 mutations
William D. Foulkes et al.
HUMAN MUTATION (2011)
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome
Ingrid Slade et al.
JOURNAL OF MEDICAL GENETICS (2011)
Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies
Ashish Dhir et al.
FEBS JOURNAL (2010)
DICER1 Mutations in Familial Pleuropulmonary Blastoma
D. Ashley Hill et al.
SCIENCE (2009)
A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation
Catherine Dehainault et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals
G Yeo et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2004)
The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons
L Perrin-Vidoz et al.
HUMAN MOLECULAR GENETICS (2002)
Share Paper
